Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 3
2003 8
2004 5
2005 4
2006 5
2007 5
2008 10
2009 10
2010 5
2011 16
2012 8
2013 3
2014 5
2015 7
2016 7
2017 3
2018 3
2019 8
2020 5
2021 12
2022 13
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug conjugates for cancer therapy.
Thomas A, Teicher BA, Hassan R. Thomas A, et al. Among authors: teicher ba. Lancet Oncol. 2016 Jun;17(6):e254-e262. doi: 10.1016/S1470-2045(16)30030-4. Lancet Oncol. 2016. PMID: 27299281 Free PMC article. Review.
Antibody-drug Conjugate Targets, Drugs, and Linkers.
Teicher BA, Morris J. Teicher BA, et al. Curr Cancer Drug Targets. 2022;22(6):463-529. doi: 10.2174/1568009622666220224110538. Curr Cancer Drug Targets. 2022. PMID: 35209819 Review.
CXCL12 (SDF-1)/CXCR4 pathway in cancer.
Teicher BA, Fricker SP. Teicher BA, et al. Clin Cancer Res. 2010 Jun 1;16(11):2927-31. doi: 10.1158/1078-0432.CCR-09-2329. Epub 2010 May 18. Clin Cancer Res. 2010. PMID: 20484021 Review.
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.
Krivtsov AV, Evans K, Gadrey JY, Eschle BK, Hatton C, Uckelmann HJ, Ross KN, Perner F, Olsen SN, Pritchard T, McDermott L, Jones CD, Jing D, Braytee A, Chacon D, Earley E, McKeever BM, Claremon D, Gifford AJ, Lee HJ, Teicher BA, Pimanda JE, Beck D, Perry JA, Smith MA, McGeehan GM, Lock RB, Armstrong SA. Krivtsov AV, et al. Among authors: teicher ba. Cancer Cell. 2019 Dec 9;36(6):660-673.e11. doi: 10.1016/j.ccell.2019.11.001. Cancer Cell. 2019. PMID: 31821784 Free PMC article.
TGFβ-Directed Therapeutics: 2020.
Teicher BA. Teicher BA. Pharmacol Ther. 2021 Jan;217:107666. doi: 10.1016/j.pharmthera.2020.107666. Epub 2020 Aug 21. Pharmacol Ther. 2021. PMID: 32835827 Free PMC article. Review.
The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models.
Kendsersky NM, Lindsay J, Kolb EA, Smith MA, Teicher BA, Erickson SW, Earley EJ, Mosse YP, Martinez D, Pogoriler J, Krytska K, Patel K, Groff D, Tsang M, Ghilu S, Wang Y, Seaman S, Feng Y, Croix BS, Gorlick R, Kurmasheva R, Houghton PJ, Maris JM. Kendsersky NM, et al. Among authors: teicher ba. Clin Cancer Res. 2021 May 15;27(10):2938-2946. doi: 10.1158/1078-0432.CCR-20-4221. Epub 2021 Feb 22. Clin Cancer Res. 2021. PMID: 33619171 Free PMC article.
SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures.
Tlemsani C, Pongor L, Elloumi F, Girard L, Huffman KE, Roper N, Varma S, Luna A, Rajapakse VN, Sebastian R, Kohn KW, Krushkal J, Aladjem MI, Teicher BA, Meltzer PS, Reinhold WC, Minna JD, Thomas A, Pommier Y. Tlemsani C, et al. Among authors: teicher ba. Cell Rep. 2020 Oct 20;33(3):108296. doi: 10.1016/j.celrep.2020.108296. Cell Rep. 2020. PMID: 33086069 Free PMC article.
Antibody drug conjugates.
Teicher BA. Teicher BA. Curr Opin Oncol. 2014 Sep;26(5):476-83. doi: 10.1097/CCO.0000000000000108. Curr Opin Oncol. 2014. PMID: 25024051 Review.
Proteasome inhibitors.
Teicher BA, Tomaszewski JE. Teicher BA, et al. Biochem Pharmacol. 2015 Jul 1;96(1):1-9. doi: 10.1016/j.bcp.2015.04.008. Epub 2015 Apr 29. Biochem Pharmacol. 2015. PMID: 25935605 Free article.
A Vision from the New Editor-in-Chief.
Teicher BA. Teicher BA. Mol Cancer Ther. 2019 Mar;18(3):497. doi: 10.1158/1535-7163.MCT-19-0094. Mol Cancer Ther. 2019. PMID: 30824580 No abstract available.
134 results